Oral Contraceptives Containing Estrogen Assignment
OBGYN SOAP Note
SUBJECTIVE DATA
CHIEF CONCERN: Abdominal pain and irregular menstrual cycles
HPI: Chief Complaint: Abdominal pain and irregular menstrual cycles
HPI (History of Present Illness):
D.P., a 34-year-old female, presents to the clinic with a chief complaint of abdominal pain and irregular menstrual cycles. She reports experiencing intermittent lower abdominal discomfort for the past three months. The pain is dull in nature, with occasional sharp, cramp-like episodes. The intensity of the pain varies but is usually mild to moderate. D.P. also notices that her menstrual cycles have become irregular, occurring every 35-45 days instead of her usual 28-day cycle. Oral Contraceptives Containing Estrogen Assignment
ORDER HERE A PLAGIARISM-FREE PAPER HERE
PMH: D.P. has a history of polycystic ovary syndrome (PCOS) diagnosed two years ago. She has been managing her condition with lifestyle modifications and has not required any specific medications or surgical interventions. She has regular check-ups with her primary care physician and gynecologist for monitoring and guidance.
SH: D.P. is married and works as a marketing executive in a corporate setting. She leads a sedentary lifestyle due to the nature of her job. She does not smoke, drink alcohol, or use recreational drugs. D.P. expresses concerns about her weight, reporting gradual weight gain over the past year.
CURRENT MEDICATIONS: currently taking any medications.
ALLERGIES: no known allergies
FAMILY HISTORY: D.P. has a family history of type 2 diabetes on her father’s side. There are no other significant gynecological or reproductive disorders reported in her immediate family.
FOCUSED ROS:
General: D.P. denies any recent weight changes, fever, fatigue, or night sweats.
Skin: No rashes, itching, or skin changes reported.
Cardiovascular: No chest pain, palpitations, or edema.
Respiratory: No shortness of breath, cough, or wheezing. Oral Contraceptives Containing Estrogen Assignment
Gastrointestinal: D.P. reports intermittent abdominal pain but denies any changes in bowel habits, nausea, vomiting, or diarrhea.
Genitourinary: Apart from irregular menstrual cycles, no urinary complaints, dysuria, or hematuria reported.
Neurological: No headaches, dizziness, or focal neurological symptoms.
Musculoskeletal: No joint pain, swelling, or limitations in mobility reported.
Psychiatric: No symptoms of anxiety, depression, or changes in mood reported.
Endocrine: D.P. has a history of PCOS and reports concerns about weight gain.
Hematological: No history of bleeding disorders or abnormal bruising reported.
OBJECTIVE DATA
PHYSICAL EXAM
Vital Signs: Heart Rate: 78 beats per minute, Respiratory Rate: 16 breaths per minute, Temperature: 98.6°F (37°C) Oxygen Saturation: 98% on room air
General: D.P. appears well-nourished and in no acute distress. She is conscious, alert, and cooperative.
Skin: No rashes, lesions, or abnormalities noted. Skin is warm and dry.
Cardio: Regular rate and rhythm, with no murmurs, gallops, or rubs detected. Peripheral pulses are equal and symmetrical. No edema in the extremities.
Resp: Clear breath sounds bilaterally. No wheezing, crackles, or decreased breath sounds.
Abdomen: soft and non-distended. No palpable masses or tenderness noted upon light and deep palpation. No organomegaly appreciated. Bowel sounds are present in all quadrants. Oral Contraceptives Containing Estrogen Assignment
GU: External genitalia: No erythema, lesions, or discharge noted. No signs of trauma.
Vaginal examination: The vaginal walls are pink, moist, and without lesions. No abnormal discharge or foul odor observed. The cervix appears normal without any visible abnormalities.
Neurologic: Cranial nerves are intact. No motor or sensory deficits noted. Normal gait and coordination observed.
Musculoskeletal: Full range of motion in all extremities. No joint swelling, tenderness, or deformities detected.
Tests: ● Urinalysis ● Hormonal Assessment ● CBC ● Pelvic Ultrasound
DIAGNOSES
5 PLAUSIBLE DIFFERENTIAL DIAGNOSES WITH ICD CODES AND RULE IN /RULE OUT SUBJECTIVE AND OBJECTIVE SUPPORTING DATA
- Polycystic Ovary Syndrome (PCOS) – E28.2 Oral Contraceptives Containing Estrogen Assignment
Reasoning: The patient has a known history of PCOS, characterized by irregular menstrual cycles, weight concerns, and a past diagnosis of this condition. The objective data includes physical signs of polycystic ovaries on pelvic ultrasound, hormonal imbalances (elevated LH/FSH ratio), and subjective symptoms such as irregular cycles and weight gain. These findings strongly support PCOS as a plausible diagnosis.
- Ovarian Cyst – N83.20
Reasoning: The patient’s abdominal pain, predominantly on the right side, along with the history of irregular menstrual cycles, suggests the possibility of an ovarian cyst. The pelvic ultrasound can help rule in or rule out the presence of an ovarian cyst by visualizing the ovaries. If an ovarian cyst is identified, it can explain the abdominal pain and irregular cycles. Oral Contraceptives Containing Estrogen Assignment
- Endometriosis – N80.9
Reasoning: Endometriosis can cause chronic pelvic pain and irregular menstrual cycles. Although not explicitly mentioned, the patient’s complaints of lower abdominal discomfort and dysmenorrhea could be indicative of endometriosis. A pelvic ultrasound may not definitively diagnose endometriosis, but it can help rule out other conditions and provide indirect support for considering this diagnosis.
- Pelvic Inflammatory Disease (PID) – N73.9 Oral Contraceptives Containing Estrogen Assignment
Reasoning: Although the patient denies any urinary or vaginal symptoms, the lower abdominal pain and tenderness elicited during the physical examination raise the possibility of PID. In some cases, patients may not exhibit classic symptoms. Further testing, such as a cervical swab for sexually transmitted infections and inflammatory markers, may be required to rule in or rule out PID.
- Hypothyroidism – E03.9
Reasoning: Hypothyroidism can lead to irregular menstrual cycles and weight gain, both of which are reported by the patient. Additionally, the patient’s concerns about weight gain and sedentary lifestyle may further support this diagnosis. A thyroid-stimulating hormone (TSH) test can be conducted to assess thyroid function and confirm or rule out hypothyroidism.
FINAL DIAGNOSIS WITH ICD CODE
Polycystic Ovary Syndrome (PCOS) – ICD-10 code E28.2. Oral Contraceptives Containing Estrogen Assignment
Polycystic Ovary Syndrome (PCOS) is a hormonal disorder that affects women of reproductive age. It is characterized by three main features: irregular menstrual cycles, excess androgen levels (male hormones), and the presence of multiple small cysts on the ovaries (Sadeghi et al., 2022). The patient’s history of irregular menstrual cycles, as well as the physical exam findings of abdominal pain and tenderness, align with the typical presentation of PCOS. Additionally, the patient has a known previous diagnosis of PCOS, further supporting this conclusion. PCOS is believed to be caused by a combination of genetic and environmental factors. Hormonal imbalances disrupt the normal menstrual cycle, leading to irregular periods. Increased androgen levels can cause symptoms such as acne, hirsutism (excessive hair growth), and weight gain (Sadeghi et al., 2022). The presence of multiple small cysts on the ovaries, visible on pelvic ultrasound, is a common finding in PCOS. Patients with PCOS may also experience other associated conditions, such as insulin resistance, obesity, type 2 diabetes, and cardiovascular disease. Therefore, it is important for individuals with PCOS to undergo regular monitoring and adopt lifestyle modifications, including maintaining a healthy weight, exercising regularly, and managing insulin resistance if present. Oral Contraceptives Containing Estrogen Assignment
TREATMENT PLAN
ORDER HERE NOW
NON-PHARMACOLOGICAL:
- Lifestyle Modifications: Provide education and support to the patient regarding the following lifestyle changes:
– Weight Management: Encourage a balanced diet and regular physical activity to achieve and maintain a healthy weight. Weight loss, even as little as 5-10%, can improve PCOS symptoms and hormone levels.
– Exercise: Recommend engaging in regular physical activity, such as aerobic exercises and strength training, for at least 150 minutes per week.
– Diet: Advise the patient to follow a balanced, low glycemic index (GI) diet with a focus on whole grains, fruits, vegetables, lean proteins, and healthy fats. Limit the intake of processed foods, sugary drinks, and refined carbohydrates. Oral Contraceptives Containing Estrogen Assignment
PATIENT EDUCATION:
- Menstrual Cycle Monitoring: Educate the patient on tracking menstrual cycles, noting cycle length, duration, and any changes in symptoms. This will help monitor improvements or identify abnormalities that may require medical intervention (Islam et al., 2022).
- Fertility Awareness: Discuss family planning options and provide information about potential fertility issues associated with PCOS. If pregnancy is desired, explain the potential challenges and available fertility treatment options.
PHARMACOLOGICAl
- Oral Contraceptives: Prescribe combination oral contraceptives containing estrogen and a progestin to regulate menstrual cycles, reduce androgen levels, and improve symptoms such as acne and hirsutism. These medications also provide contraception (Kumarendran et al., 2021).
FOLLOW UP:
Follow-up in two weeks to assess the patient’s progress, evaluate treatment effectiveness, and address any concerns or questions.
REFERRAL:
No referral needed at this time. Oral Contraceptives Containing Estrogen Assignment
REFERENCES
Islam, H., Masud, J., Islam, Y. N., & Haque, F. K. M. (2022). An update on polycystic ovary syndrome: A review of the current state of knowledge in diagnosis, genetic etiology, and emerging treatment options. Women’s Health, 18, 17455057221117966.
Kumarendran, B., O’Reilly, M. W., Subramanian, A., Šumilo, D., Toulis, K., Gokhale, K. M., … & Nirantharakumar, K. (2021). Polycystic ovary syndrome, combined oral contraceptives, and the risk of dysglycemia: a population-based cohort study with a nested pharmacoepidemiological case-control study. Diabetes care, 44(12), 2758-2766.
Sadeghi, H. M., Adeli, I., Calina, D., Docea, A. O., Mousavi, T., Daniali, M., … & Abdollahi, M. (2022). Polycystic ovary syndrome: a comprehensive review of pathogenesis, management, and drug repurposing. International journal of molecular sciences, 23(2), 583. Oral Contraceptives Containing Estrogen Assignment